InvestorsHub Logo
Followers 38
Posts 3346
Boards Moderated 0
Alias Born 01/13/2017

Re: flipper44 post# 233298

Friday, 06/14/2019 1:00:33 PM

Friday, June 14, 2019 1:00:33 PM

Post# of 710601
NWBO is priced like this is the only chess move left and I'm fine with those odds. But is LL fooling herself into believing that the results shes seeing are due to dcvax? I say this with sincerity. Perhaps the patients would've rebooted their immune response after SOC anyway. 5 ALA would provide that chance to a natural recovery the same way it opens the door for dcvax. It also becomes easier to fool yourself when the benefit is seen in the mgmt methylated patients, which could be why she always has a frog in her throat when describing brads histology and mgmt +. I get the vibe that she knows people can make that argument against her but still feels dcvax is at work.

The delta between GTR and partial resection might make it arguable that recurrence isn't as big a barrier as we think, if dcvax is actually having an effect, which would lend itself back to crossover issues.

I'm still okay with these odds.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News